Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

102.27 -0.24 (-0.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,711,878
Open 102.69
Bid (Size) 101.81 (200)
Ask (Size) 102.86 (200)
Prev. Close 102.51
Today's Range 102.13 - 102.69
52wk Range 38.81 - 102.70
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC is Investigating SKYT, EXAS, GORO, MOVE on Behalf of Shareholders
Shareholders should contact the firm as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
From Exact Sciences Corp.
Via Business Wire

Performance

YTD
+0.5%
+0.5%
1 Month
+0.6%
+0.6%
3 Month
+46.9%
+46.9%
6 Month
+116.8%
+116.8%
1 Year
+86.8%
+86.8%

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide
From Exact Sciences Corp.
Via Business Wire
News headline image
Halper Sadeh LLC Reminds Shareholders of EXAS, DVN, NFBK of the Firm’s Investigations
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
The Best Dividend King to Buy With $150 ↗
Via The Motley Fool
News headline image
Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race
Via MarketMinute
Topics Artificial Intelligence
News headline image
3 Reasons to Buy This Dividend King After Its Steep Sell-Off ↗
Via The Motley Fool
Topics Earnings
News headline image
Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness
Via MarketMinute
Topics Economy
News headline image
Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat
Via MarketMinute
Topics Earnings Economy
News headline image
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
$5.1 Trillion Global Surge: CEO Confidence Ignites New Era of M&A Transformation
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Halper Sadeh LLC Encourages SEE, EXAS, ZEUS Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside
Via AB Newswire
Topics Intellectual Property
News headline image
The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A
Via MarketMinute
Topics Artificial Intelligence
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
Via MarketMinute
News headline image
Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization
Via MarketMinute
News headline image
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
Via MarketMinute
Topics Artificial Intelligence Death
News headline image
Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
3 Mid-Cap Stocks We Steer Clear Of
Via StockStory
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
1 High-Flying Stock on Our Watchlist and 2 We Question
Via StockStory
News headline image
3 Unpopular Stocks We Steer Clear Of
Via StockStory
News headline image
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
From Exact Sciences Corp.
Via Business Wire
News headline image
1 Healthcare Stock for Long-Term Investors and 2 We Avoid
Via StockStory
Topics Stocks

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 102.27
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 02/04/26 04:00 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 17.59B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 18B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.